RESEARCH ARTICLE The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C- Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population

Vuilleumier, Nicolas
Antiochos, Panagiotis
Marques-Vidal, Pedro
Pagano, Sabrina
Virzi, Julien
Satta, Nathalie
Hartley, Oliver
Gaertner, Hubert
Brandt, Karim J
Burger, Fabienne
Montecucco, Fabrizio
Waeber, Gerard
Mach, François
Vollenweider, Peter

January 2020

Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.

Vuilleumier, N.
Antiochos, P.
Marques-Vidal, P.
Pagano, S.
Virzi, J.
Satta, N.
Hartley, O.
Gaertner, H.
Brandt, K.J.
Burger, F.
Montecucco, F.
Waeber, G.
Mach, F.
Vollenweider, P.

January 2020

Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (cter apoA1) ha...

Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases

Teixeira, Priscila Camillo
Ducret, Axel
Ferber, Philippe
Gaertner, Hubert François
Hartley, Oliver
Pagano, Sabrina
Butterfield, Michelle
Langen, Hanno
Vuilleumier, Nicolas
Cutler, Paul

January 2014

Autoantibodies to apolipoprotein A-I (anti-apoA-I IgG) have been shown to be both markers and mediat...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Pagano, Sabrina
Gaertner, Hubert François
Cerini, Fabrice
Mannic, Tiphaine
Satta, Nathalie
Teixeira, Priscila Camillo
Cutler, Paul
Mach, François
Vuilleumier, Nicolas
Hartley, Oliver

January 2015

Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both dia...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? - Table 2

Sabrina Pagano (770732)
Hubert Gaertner (770733)
Fabrice Cerini (770734)
Tiphaine Mannic (497675)
Nathalie Satta (36519)
Priscila Camillo Teixeira (215714)
Paul Cutler (770735)
François Mach (543633)
Nicolas Vuilleumier (703289)
Oliver Hartley (236596)

July 2015

<p>*P value was computed by comparing patients with high vs low anti-F3L1 immunoreactivity. CHD: cor...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Sabrina Pagano
Hubert Gaertner
Fabrice Cerini
Tiphaine Mannic
Nathalie Satta
Priscila Camillo Teixeira
Paul Cutler
François Mach
Nicolas Vuilleumier
Oliver Hartley

Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both dia...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Pagano Sabrina
Gaertner Hubert
Cerini Fabrice
Mannic Tiphaine
Satta Nathalie
Teixeira Priscila Camillo
Cutler Paul
Mach François
Vuilleumier Nicolas
Hartley Oliver

July 2015

Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both dia...

[ Downloaded 10/05/2016 at 04:01:12]

September 2016

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity VUILLEUMIER, Nico...

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

Vuilleumier, Nicolas

January 2013

Immune-driven inflammation plays an important part in atherogenesis, and is therefore believed to be...

Review Article Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives

P. C. Teixeira
P. Cutler
N. Vuilleumier

January 2012

Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.

Goncalves, Isabel
Nitulescu, Michaela
Ares, Mikko PS
Nordin Fredrikson, Gunilla
Jansson, Bo
Li, Zhan-Chun
Nilsson, Jan

January 2009

PURPOSE: Accumulation of oxidized LDL in the arterial wall is believed to play a key role in the dev...

Research Article Autoantibodies Targeting AT1 Receptor from Patients with Acute Coronary Syndrome Upregulate Proinflammatory Cytokines Expression in Endothelial Cells Involving NF-

Weijuan Li
Zhi Li
Yaoqi Chen
Songhai Li
Yuanyuan Lv
Wenping Zhou
Mengyang Liao
Feng Zhu
Zihua Zhou
Xiang Cheng
Qiutang Zeng
Yuhua Liao
Yumiao Wei

September 2016

which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...

Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.

Goncalves, Isabel
Nitulescu, Mihaela
Ares, Mikko
Nordin Fredrikson, Gunilla
Jansson, Bo
Li, Zhan-Chun
Nilsson, Jan

January 2009

PURPOSE: Accumulation of oxidized LDL in the arterial wall is believed to play a key role in the dev...

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

Vuilleumier, Nicolas
Montecucco, Fabrizio
Hartley, Oliver

January 2014

Immune-driven inflammation plays an important part in atherogenesis and is therefore believed to be ...

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

Vuilleumier, Nicolas
Antiochos, Panagiotis
Marques‐Vidal, Pedro
Pagano, Sabrina
Virzi, Julien
Satta Poschung, Nathalie
Hartley, Oliver
Gaertner, Hubert François
Brandt, Karim
Burger, Fabienne
Montecucco, Fabrizio
Waeber, Gerard
Mach, François
Vollenweider, Peter

January 2020

Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population

Vuilleumier, Nicolas
Antiochos, Panagiotis
Marques-Vidal, Pedro
Pagano, Sabrina
Virzi, Julien
Satta, Nathalie
Hartley, Oliver
Gaertner, Hubert
Brandt, Karim J
Burger, Fabienne
Montecucco, Fabrizio
Waeber, Gerard
Mach, François
Vollenweider, Peter

January 2020

Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.

Vuilleumier, N.
Antiochos, P.
Marques-Vidal, P.
Pagano, S.
Virzi, J.
Satta, N.
Hartley, O.
Gaertner, H.
Brandt, K.J.
Burger, F.
Montecucco, F.
Waeber, G.
Mach, F.
Vollenweider, P.

January 2020

Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (cter apoA1) ha...

Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases

Teixeira, Priscila Camillo
Ducret, Axel
Ferber, Philippe
Gaertner, Hubert François
Hartley, Oliver
Pagano, Sabrina
Butterfield, Michelle
Langen, Hanno
Vuilleumier, Nicolas
Cutler, Paul

January 2014

Autoantibodies to apolipoprotein A-I (anti-apoA-I IgG) have been shown to be both markers and mediat...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Pagano, Sabrina
Gaertner, Hubert François
Cerini, Fabrice
Mannic, Tiphaine
Satta, Nathalie
Teixeira, Priscila Camillo
Cutler, Paul
Mach, François
Vuilleumier, Nicolas
Hartley, Oliver

January 2015

Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both dia...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? - Table 2

Sabrina Pagano (770732)
Hubert Gaertner (770733)
Fabrice Cerini (770734)
Tiphaine Mannic (497675)
Nathalie Satta (36519)
Priscila Camillo Teixeira (215714)
Paul Cutler (770735)
François Mach (543633)
Nicolas Vuilleumier (703289)
Oliver Hartley (236596)

July 2015

<p>*P value was computed by comparing patients with high vs low anti-F3L1 immunoreactivity. CHD: cor...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Sabrina Pagano
Hubert Gaertner
Fabrice Cerini
Tiphaine Mannic
Nathalie Satta
Priscila Camillo Teixeira
Paul Cutler
François Mach
Nicolas Vuilleumier
Oliver Hartley

Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both dia...

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Pagano Sabrina
Gaertner Hubert
Cerini Fabrice
Mannic Tiphaine
Satta Nathalie
Teixeira Priscila Camillo
Cutler Paul
Mach François
Vuilleumier Nicolas
Hartley Oliver

July 2015

Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both dia...

[ Downloaded 10/05/2016 at 04:01:12]

September 2016

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity VUILLEUMIER, Nico...

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

Vuilleumier, Nicolas

January 2013

Immune-driven inflammation plays an important part in atherogenesis, and is therefore believed to be...

Review Article Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives

P. C. Teixeira
P. Cutler
N. Vuilleumier

January 2012

Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.

Goncalves, Isabel
Nitulescu, Michaela
Ares, Mikko PS
Nordin Fredrikson, Gunilla
Jansson, Bo
Li, Zhan-Chun
Nilsson, Jan

January 2009

PURPOSE: Accumulation of oxidized LDL in the arterial wall is believed to play a key role in the dev...

Research Article Autoantibodies Targeting AT1 Receptor from Patients with Acute Coronary Syndrome Upregulate Proinflammatory Cytokines Expression in Endothelial Cells Involving NF-

Weijuan Li
Zhi Li
Yaoqi Chen
Songhai Li
Yuanyuan Lv
Wenping Zhou
Mengyang Liao
Feng Zhu
Zihua Zhou
Xiang Cheng
Qiutang Zeng
Yuhua Liao
Yumiao Wei

September 2016

which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...

Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.

Goncalves, Isabel
Nitulescu, Mihaela
Ares, Mikko
Nordin Fredrikson, Gunilla
Jansson, Bo
Li, Zhan-Chun
Nilsson, Jan

January 2009

PURPOSE: Accumulation of oxidized LDL in the arterial wall is believed to play a key role in the dev...

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

Vuilleumier, Nicolas
Montecucco, Fabrizio
Hartley, Oliver

January 2014

Immune-driven inflammation plays an important part in atherogenesis and is therefore believed to be ...

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

Vuilleumier, Nicolas
Antiochos, Panagiotis
Marques‐Vidal, Pedro
Pagano, Sabrina
Virzi, Julien
Satta Poschung, Nathalie
Hartley, Oliver
Gaertner, Hubert François
Brandt, Karim
Burger, Fabienne
Montecucco, Fabrizio
Waeber, Gerard
Mach, François
Vollenweider, Peter

January 2020

Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population

Vuilleumier, Nicolas
Antiochos, Panagiotis
Marques-Vidal, Pedro
Pagano, Sabrina
Virzi, Julien
Satta, Nathalie
Hartley, Oliver
Gaertner, Hubert
Brandt, Karim J
Burger, Fabienne
Montecucco, Fabrizio
Waeber, Gerard
Mach, François
Vollenweider, Peter

January 2020

Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (ct...

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.

Vuilleumier, N.
Antiochos, P.
Marques-Vidal, P.
Pagano, S.
Virzi, J.
Satta, N.
Hartley, O.
Gaertner, H.
Brandt, K.J.
Burger, F.
Montecucco, F.
Waeber, G.
Mach, F.
Vollenweider, P.

January 2020

Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (cter apoA1) ha...

Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases

Teixeira, Priscila Camillo
Ducret, Axel
Ferber, Philippe
Gaertner, Hubert François
Hartley, Oliver
Pagano, Sabrina
Butterfield, Michelle
Langen, Hanno
Vuilleumier, Nicolas
Cutler, Paul

January 2014

Autoantibodies to apolipoprotein A-I (anti-apoA-I IgG) have been shown to be both markers and mediat...

RESEARCH ARTICLE The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C- Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Abstract

Extracted data

RESEARCH ARTICLE The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C- Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Abstract

Extracted data

Related items

Related items